(Q68368880)
Statements
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity (English)
Abbruzzese JL
Levin B
Faintuch JS
Pazdur R
Saks S
Edwards C
Gutterman JU
1 October 1990